Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Halozyme Therapeutics Inc shares valued at $271,467 were sold by Henderson Jeffrey William on Apr 28 ’25. At $60.37 per share, Henderson Jeffrey William sold 4,497 shares. The insider’s holdings dropped to 28,611 shares worth approximately $1.4 million following the completion of this transaction.
Also, Henderson Jeffrey William sold 503 shares, netting a total of over 32,217 in proceeds. Following the sale of shares at $64.05 each, the insider now holds 33,108 shares.
Before that, Henderson Jeffrey William had sold 5,000 shares from its account. In a trade valued at $293,458, the Director traded Halozyme Therapeutics Inc shares for $58.69 each. Upon closing the transaction, the insider’s holdings decreased to 5,000 shares, worth approximately $1.65 million.
As published in a research note from Morgan Stanley on May 14, 2025, Halozyme Therapeutics Inc [HALO] has been rated down from an Overweight to an Equal-weight and the price target has been revised to $62. Analysts at Leerink Partners downgraded the stock from ‘”a Market perform”‘ to ‘”an Underperform”‘ outlook in a report released in mid May. As of October 07, 2024, Wells Fargo has decreased its “an Overweight” rating to a “an Equal weight” for HALO. Earlier on September 19, 2024, JP Morgan downgraded its rating. Their new recommendation was “a Neutral” for HALO stock which previously was a “an Overweight”.
Analyzing HALO Stock Performance
During the last five days, there has been a drop of approximately -27.73%. Over the course of the year, Halozyme Therapeutics Inc shares have jumped approximately 2.38%. Shares of the company reached a 52-week high of $70.50 on 05/07/25 and a 52-week low of $47.50 on 05/14/25. A 50-day SMA is recorded $60.99, while a 200-day SMA reached $56.40.
Support And Resistance Levels for Halozyme Therapeutics Inc (HALO)
According to the 24-hour chart, there is a support level at 47.89, which, if violated, would cause prices to drop to 46.84. In the upper region, resistance lies at 49.85. The next price resistance is at 50.76. RSI (Relative Strength Index) is 34.26 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -11.07, which suggests the price will decrease in the coming days. Percent R is at 93.70%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
